Xiangyu Zhang
Nanjing, 211198, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Rising Star in Immunotherapy: Development and Therapeutic Potential of Small-Molecule Inhibitors Targeting Casitas B Cell Lymphoma-b (Cbl-b).
Journal: Journal of medicinal chemistry
Published: January 05, 2024
Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer.
Journal: Journal of medicinal chemistry
Published: January 03, 2023
Discovery of Small Molecules Simultaneously Targeting NAD(P)H:Quinone Oxidoreductase 1 and Nicotinamide Phosphoribosyltransferase: Treatment of Drug-Resistant Non-small-Cell Lung Cancer.
Journal: Journal of medicinal chemistry
Published: May 31, 2022
Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).
Journal: Mini reviews in medicinal chemistry
Published: February 03, 2022
Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells.
Journal: Frontiers in pharmacology
Published: May 09, 2020
Aspirin potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer by targeting GRP78 activity.
Journal: Therapeutic advances in medical oncology
Published: November 08, 2019
ADT-OH, a hydrogen sulfide-releasing donor, induces apoptosis and inhibits the development of melanoma in vivo by upregulating FADD.
Journal: Cell death & disease
Published: May 18, 2019
Last Updated: 09/26/2026